HemaSphere (Aug 2022)

P-031: TRANSITION FROM LONG TERM HIGH DOSE FULL AGONIST OPIOIDS TO BUPRENORPHINE IN THE INPATIENT SETTING FOR PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE: A MODIFIED INDIVIDUALIZED MICRO INDUCTION APPROACH. A SINGLE CENTER EXPERIENCE

  • SAAH E.,
  • PITTS R.,
  • NEW T.,
  • STERNER-ALLISON J.,
  • GIANNOPOULOS H.,
  • GEE B.

DOI
https://doi.org/10.1097/01.HS9.0000873020.74348.64
Journal volume & issue
Vol. 6
pp. 32 – 33

Abstract

Read online

No abstracts available.